EU Regulators Charge J&J, Novartis Over Dutch Painkiller Delay

EU antitrust regulators stepped up their fight against companies blocking the market entry of cheaper generic medicines, with charges against Johnson & Johnson and Novartis over a pay-for-delay deal in the Netherlands.

This is the third such case launched by the European Commission after it filed charges against Merck KGaA, Lundbeck, Servier and several other pharmaceutical companies last year.

Regulators on both sides of the Atlantic have warned pharmaceutical firms against agreements where brand-name companies pay generic competitors to withhold their rival drugs from the market, saying such deals result in additional costs for consumers.

The Commission, which acts as antitrust regulator in the 27-nation European Union, said it had sent a "statement of objections" or charge sheet to Johnson & Johnson and Novartis over an agreement between their Dutch subsidiaries.

"If our preliminary conclusions are confirmed, the Dutch subsidiaries of Johnson & Johnson and Novartis entered into a so-called 'co-promotion' agreement to avoid competing against each other, depriving users of fentanyl in the Netherlands from access to a cheaper painkiller," the Commission said in a statement.

It said the agreement meant Dutch consumers were not able to get access to cheaper generic fentanyl from July 2005 to December 2006.

The charges arose from an investigation of the pharmaceuticals sector after a Commission report highlighted deals between major drugmakers aimed at hindering or blocking generic medicines in "pay-for-delay" deals.

The EU executive can fine companies up to 10% of their global sales for breaching EU antitrust rules.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.